We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$1.6B
AUM Growth
+$49.8M
Cap. Flow
-$8.91M
Cap. Flow %
-0.56%
Top 10 Hldgs %
41.26%
Holding
86
New
5
Increased
35
Reduced
26
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 38.16%
2 Healthcare 29.89%
3 Industrials 14.32%
4 Financials 7.72%
5 Consumer Discretionary 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOGM
76
DELISTED
LogMein, Inc.
LOGM
$202K 0.01%
1,840
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.13T
-1,500
Closed -$254K
HURN icon
78
Huron Consulting
HURN
$2.42B
-40,899
Closed -$1.77M
RBA icon
79
RB Global
RBA
$17.5B
-7,200
Closed -$207K
XOM icon
80
ExxonMobil
XOM
$634B
-2,710
Closed -$219K
GWR
81
DELISTED
Genesee & Wyoming Inc.
GWR
-8,100
Closed -$554K
AMRI
82
DELISTED
Albany Molecular Research Inc
AMRI
-2,577,470
Closed -$55.9M
ABAX
83
DELISTED
Abaxis Inc
ABAX
-80,000
Closed -$4.24M
WOOF
84
DELISTED
VCA Inc.
WOOF
-12,800
Closed -$1.18M

Similar funds

American Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, American Capital Management held 86 positions worth $1.6B, up 3.2% from $1.55B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

American Capital Management's Q3 2017 filing shows 5 new, 35 increased, 26 reduced and 8 closed positions. Its largest new stake was Kornit Digital: 1,089,968 shares worth $16.7M. The largest sale was Albany Molecular Research Inc, an estimated $55.9M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q3 2017 buy was Kornit Digital: 1,089,968 shares worth $16.7M.
  • American Capital Management added most to CyberArk in Q3 2017, an estimated $12.6M increase.
  • American Capital Management's biggest Q3 2017 reduction was Cognex, cutting an estimated $2.9M.
  • American Capital Management fully exited Albany Molecular Research Inc in Q3 2017, selling an estimated $55.9M.
  • American Capital Management's ten largest holdings make up 41% of its $1.6B portfolio in Q3 2017.
  • American Capital Management opened 5 new positions and closed 8 in Q3 2017.
  • American Capital Management's portfolio value rose 3.2% quarter-over-quarter to $1.6B.

Based on American Capital Management's 13F filing for Q3 2017, filed 20 Oct 2017.